ArticleNucleic acids research2025
Residues in the little finger domain of the Y-family Dpo4 DNA polymerase communicate to restrict synthesis past 8-oxoguanine lesions.
Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Endogenous reactive oxygen species are responsible for abundant 8-oxo-7,8-dihydroguanine (8-oxoG) lesion formation in all three domains of life. In the archaeal Saccharolobus solfataricus(Sso), a specialized translesion synthesis (TLS) polymerase, SsoDpo4, is recruited to bypass lesions when the high-fidelity polymerase stalls. Previous studies have found that SsoDpo4 can accurately bypass 8-oxoG lesions with deoxycytosine and then efficiently extend three nucleotides beyond the lesion to the +3 position. Here, we have mutated several arginines within the little finger (LF) domain that track along the phosphate backbone near the active site and tested their extension ability and DNA binding properties. Mutation of two key residues, R332 or R336, to alanine relieves +3 intermediate accumulation, resulting in more efficient full-length extension. Interestingly, the wild-type enzyme binds progressively weaker downstream of a bypassed 8-oxoG lesion, indicating decreased binding stability after lesion bypass. X-ray crystallography has captured these mutants on the +3 extended primer/8-oxoG template to structurally characterize how these LF residues communicate to restrict downstream synthesis past 8-oxoG. Our results offer mechanistic and structural insights into how TLS polymerases restrict downstream synthesis past a lesion by sensing backbone distortions and altering domain conformations to limit catalysis and destabilize binding.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.